Skip to main content

Peer Review reports

From: HER2 exon 20 insertion mutations and myelosuppression in lung adenocarcinoma patient: a case report and response to trastuzumab deruxtecan

Original Submission
18 May 2022 Submitted Original manuscript
14 Jul 2022 Reviewed Reviewer Report
2 Sep 2022 Author responded Author comments - Chuan Chen
Resubmission - Version 2
2 Sep 2022 Submitted Manuscript version 2
5 Dec 2022 Reviewed Reviewer Report
6 Mar 2023 Author responded Author comments - Chuan Chen
Resubmission - Version 3
6 Mar 2023 Submitted Manuscript version 3
Publishing
12 Mar 2023 Editorially accepted
3 Apr 2023 Article published 10.1186/s13019-023-02181-w

You can find further information about peer review here.

Back to article page